Showing results (411-420 of 446) with videos related to

Sort By:
Pageof 45
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acidRozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trialsRish K Pai, David E Kleiner, John Hart, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 18, 2021
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 LocusAli Bayoumi, Asmaa Elsayed, Shuanglin Han, et al.
Hepatology Communications|April 12, 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanismsChristian A Hudert, Leon A Adams, Anna Alisi, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western EuropeCarla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
Hepatology International|October 2, 2020
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseMohammed Eslam, Shiv K Sarin, Vincent Wai-Sun Wong, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsClémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
Pageof 45